The coming of age of 1,25-dihydroxyvitamin D3 analogs as immunomodulatory agents
Top Cited Papers
- 1 April 2002
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 8 (4) , 174-179
- https://doi.org/10.1016/s1471-4914(02)02294-3
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- In Vitro and In Vivo Analysis of the Immune System of Vitamin D Receptor Knockout MiceJournal of Bone and Mineral Research, 2001
- Potent Inhibition of Dendritic Cell Differentiation and Maturation by Vitamin D AnalogsBiochemical and Biophysical Research Communications, 2000
- Recent developments in the use of vitamin D analoguesExpert Opinion on Investigational Drugs, 2000
- PREVENTION OF AUTOIMMUNE DESTRUCTION OF SYNGENEIC ISLET GRAFTS IN SPONTANEOUSLY DIABETIC NONOBESE DIABETIC MICE BY A COMBINATION OF AVITAMIN D3 ANALOG AND CYCLOSPORINE1Transplantation, 1998
- Partial prevention of active Heymann nephritis by 1α, 25 dihydroxyvitamin D3Clinical and Experimental Immunology, 1993
- Two novel vitamin D analogues, KH 1060 and CB 966, prolong skin allograft survival in miceTransplant Immunology, 1993
- Single and combined effects of the vitamin D analogue KH1060 and cyclosporin A on mercuric-chloride-induced autoimmune disease in the BN ratClinical and Experimental Immunology, 1992
- In vivo beneficial effects of cyclosporin A and 1,25-dihydroxyvitamin D3 on the induction of experimental autoimmune thyroiditisClinical Immunology and Immunopathology, 1990
- Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA.Journal of Clinical Investigation, 1987
- 1,25‐Dihydroxyvitamin D3 enhances prostaglandin E2 production by monocytesFEBS Letters, 1986